{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:17:02Z","timestamp":1787008622321,"version":"build-2736575974"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Advanced human immunodeficiency virus (HIV) disease is a major cause of morbidity and mortality in people with HIV in Latin America. It remains unclear whether mortality differs between people with advanced HIV who are treatment naive (TN) and those who have discontinued antiretroviral treatment (TD). We compared mortality differences between hospitalized TN and TD individuals with advanced HIV.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>All adults hospitalized for advanced HIV disease (CD4 count &amp;lt;200\u2005cells\/\u03bcL or with AIDS-defining events) at a tertiary center in Mexico City between January 2015 and December 2022 were included. The primary outcome was 1-year mortality following hospitalization. Secondary outcomes were overall mortality and 30-day mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Four hundred seventy hospitalizations occurred in 299 adults with advanced HIV. Of these, 214 (72%) were TN at the time of admission, while 85 (28%) were TD. The median CD4 cell count was 76\u2005cells\/\u03bcL and AIDS-related infections accounted for most of the deaths. No differences were found between the groups regarding hospitalization days, CD4 cell count, or comorbidities. TD were more likely to have acquired HIV by sexual transmission (P = .009). One-year mortality was significantly higher in the TD group (24% vs 8%; P = .008). The overall mortality was also higher among TD individuals (P = .008). Multivariate analysis revealed an independent association between treatment discontinuation and mortality (hazard ratio, 2.08 [95% confidence interval, 1.14\u20133.78]).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Treatment discontinuation is associated with worse clinical outcomes when compared to TN patients. Future research should focus on understanding the reasons for these findings to develop public health strategies to prevent disruption of the continuum of care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciaf175","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T07:47:42Z","timestamp":1743493662000},"page":"e108-e114","source":"Crossref","is-referenced-by-count":5,"title":["Differences in Mortality Between Treatment-Naive and Treatment-Discontinuing Hospitalized Individuals With Advanced HIV Disease: A Comparative Retrospective Study From Mexico City"],"prefix":"10.1093","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-9735-3892","authenticated-orcid":false,"given":"H\u00e9ctor","family":"Rivera-Villegas","sequence":"first","affiliation":[{"name":"Infectious Diseases Department, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n , Mexico City ,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanink","family":"Caro-Vega","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n , Mexico City ,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6552-7928","authenticated-orcid":false,"given":"Andr\u00e9","family":"Trujillo-Gamboa","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n , Mexico City ,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7128-2242","authenticated-orcid":false,"given":"\u00c1lvaro","family":"Lopez-I\u00f1iguez","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n , Mexico City ,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Sierra-Madero","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n , Mexico City ,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2587-1123","authenticated-orcid":false,"given":"Brenda","family":"Crabtree-Ramirez","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n , Mexico City ,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"2025110901582167300_ciaf175-B1","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1186\/s12879-023-08521-4","article-title":"Prevalence and trends of advanced HIV disease among antiretroviral therapy\u2013naive and antiretroviral therapy\u2013experienced patients in South Africa between 2010\u20132021: a systematic review and meta-analysis","volume":"23","author":"Kitenge","year":"2023","journal-title":"BMC Infect Dis"},{"key":"2025110901582167300_ciaf175-B2","doi-asserted-by":"crossref","first-page":"e25642","DOI":"10.1002\/jia2.25642","article-title":"Prevalence of and factors associated with advanced HIV disease among newly diagnosed people living with HIV in Guangdong Province, China","volume":"23","author":"Jiang","year":"2020","journal-title":"J Int AIDS Soc"},{"key":"2025110901582167300_ciaf175-B3","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.1016\/S2352-3018(23)00272-2","article-title":"Longitudinal trends in causes of death among adults with HIV on antiretroviral therapy in Europe and North America from 1996 to 2020: a collaboration of cohort studies","volume":"11","author":"Trickey","year":"2024","journal-title":"Lancet HIV"},{"key":"2025110901582167300_ciaf175-B4","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1016\/S2352-3018(15)00137-X","article-title":"Causes of hospital admission among people living with HIV worldwide: a systematic review and meta-analysis","volume":"2","author":"Ford","year":"2015","journal-title":"Lancet HIV"},{"key":"2025110901582167300_ciaf175-B5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4314\/ahs.v21i1.6S","article-title":"Predictors of antiretroviral therapy interruptions and factors influencing return to care at the Nkolndongo Health District, Cameroon","volume":"21","author":"Nsoh","year":"2021","journal-title":"Afr Health Sci"},{"key":"2025110901582167300_ciaf175-B6","volume-title":"The path that ends AIDS: UNAIDS global AIDS update 2023","author":"Joint United Nations Programme on HIV\/AIDS (UNAIDS)","year":"2023"},{"key":"2025110901582167300_ciaf175-B7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12981-022-00496-7","article-title":"The impacts of COVID-19 pandemic on service delivery and treatment outcomes in people living with HIV: a systematic review","volume":"20","author":"SeyedAlinaghi","year":"2023","journal-title":"AIDS Res Ther"},{"key":"2025110901582167300_ciaf175-B8","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2174\/1570162X21666230717150555","article-title":"Late diagnosis at entry on care in an HIV clinic in Mexico City: possibly COVID-19 pandemic impact","volume":"21","author":"Elizalde-Barrera","year":"2023","journal-title":"Curr HIV Res"},{"key":"2025110901582167300_ciaf175-B9","doi-asserted-by":"crossref","first-page":"e26230","DOI":"10.1002\/jia2.26230","article-title":"Reasons for disengagement from antiretroviral care in the era of \u2018treat all\u2019 in low- or middle-income countries: a systematic review","volume":"27","author":"Burke","year":"2024","journal-title":"J Int AIDS Soc"},{"key":"2025110901582167300_ciaf175-B10","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1016\/S2352-3018(18)30356-4","article-title":"Mexico's fragmented health system as a barrier to HIV care","volume":"6","author":"Sierra-Madero","year":"2019","journal-title":"Lancet HIV"},{"key":"2025110901582167300_ciaf175-B11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1089\/aid.2015.0379","article-title":"Late presentation HIV\/AIDS is still a challenge in Brazil and worldwide","volume":"34","author":"Komninakis","year":"2018","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2025110901582167300_ciaf175-B12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10461-011-0097-6","article-title":"Predictors of late presentation for HIV diagnosis: a literature review and suggested way forward","volume":"17","author":"Mukolo","year":"2013","journal-title":"AIDS Behav"},{"key":"2025110901582167300_ciaf175-B13","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1097\/QAD.0000000000000410","article-title":"Delayed HIV diagnosis and initiation of antiretroviral therapy: inequalities by educational level, COHERE in EuroCoord","volume":"28","author":"Zangerle","year":"2014","journal-title":"AIDS"},{"key":"2025110901582167300_ciaf175-B14","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/j.1365-3156.2011.02828.x","article-title":"Unstructured treatment interruption of antiretroviral therapy in clinical practice: a systematic review","volume":"16","author":"Kranzer","year":"2011","journal-title":"Trop Med Int Health"},{"key":"2025110901582167300_ciaf175-B15","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1080\/09540121.2016.1179253","article-title":"Movement between facilities for HIV care among a mobile population in Kenya: transfer, loss to follow-up, and reengagement","volume":"28","author":"Hickey","year":"2016","journal-title":"AIDS Care"},{"key":"2025110901582167300_ciaf175-B16","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3390\/jcm10040716","article-title":"Impact of advanced HIV disease on quality of life and mortality in the era of combined antiretroviral treatment","volume":"10","author":"Portilla-Tamarit","year":"2021","journal-title":"J Clin Med"},{"key":"2025110901582167300_ciaf175-B17","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1093\/cid\/cix1139","article-title":"Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy","volume":"66","author":"Ford","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2025110901582167300_ciaf175-B18","doi-asserted-by":"crossref","first-page":"m441","DOI":"10.1136\/bmj.m441","article-title":"Calculating the sample size required for developing a clinical prediction model","volume":"368","author":"Riley","year":"2020","journal-title":"BMJ"},{"key":"2025110901582167300_ciaf175-B19","author":"British HIV Association"},{"key":"2025110901582167300_ciaf175-B20","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1016\/S2352-3018(22)00363-0","article-title":"Recommendations for defining preventable HIV-related mortality for public health monitoring in the era of Getting to Zero: an expert consensus","volume":"10","author":"Croxford","year":"2023","journal-title":"Lancet HIV"},{"key":"2025110901582167300_ciaf175-B21","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/aje\/kwz252","article-title":"The population impact of late presentation with advanced HIV disease and delayed antiretroviral therapy in adults receiving HIV care in Latin America","volume":"189","author":"Belaunzar\u00e1n-Zamudio","year":"2020","journal-title":"Am J Epidemiol"},{"key":"2025110901582167300_ciaf175-B22","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1097\/QAD.0000000000000879","article-title":"Effects of integrated interventions on transmission risk and care continuum outcomes in persons living with HIV: meta-analysis, 1996\u20132014","volume":"29","author":"Crepaz","year":"2015","journal-title":"AIDS"},{"key":"2025110901582167300_ciaf175-B23","doi-asserted-by":"crossref","first-page":"ofac611","DOI":"10.1093\/ofid\/ofac611","article-title":"Persistent high burden and mortality associated with advanced HIV disease in rural Tanzania despite uptake of World Health Organization \u2018test and treat\u2019 guidelines","volume":"9","author":"St\u00f6ger","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"2025110901582167300_ciaf175-B24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/jac\/dkac361","article-title":"Mortality and immunovirological outcomes in patients with advanced HIV disease on their first antiretroviral treatment: differential impact of antiretroviral regimens","volume":"78","author":"Burgos","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"2025110901582167300_ciaf175-B25","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12981-017-0186-3","article-title":"Hospitalization causes and outcomes in HIV patients in the late antiretroviral era in Colombia","volume":"14","author":"\u00c1lvarez Barreneche","year":"2017","journal-title":"AIDS Res Ther"},{"key":"2025110901582167300_ciaf175-B26","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1097\/QAD.0000000000003859","article-title":"The effect of unplanned care interruptions on the mortality of adults resuming antiretroviral therapy in South Africa: a survival analysis","volume":"38","author":"Moolla","year":"2024","journal-title":"AIDS"},{"issue":"Suppl 2","key":"2025110901582167300_ciaf175-B27","first-page":"163","article-title":"Mortalidad hospitalaria en pacientes con infecci\u00f3n por VIH: a diez a\u00f1os del acceso universal a TARAA en M\u00e9xico","volume":"57","author":"Mart\u00edn-Onraet","year":"2015","journal-title":"Salud Publica Mex"},{"key":"2025110901582167300_ciaf175-B28","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.3390\/ijerph16111899","article-title":"Understanding global HIV stigma and discrimination: are contextual factors sufficiently studied? (GAPresearch)","volume":"16","author":"Tran","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"2025110901582167300_ciaf175-B29","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1097\/QAD.0000000000003006","article-title":"Incidence of HIV-positive admission and inpatient mortality in Malawi (2012\u20132019)","volume":"35","author":"Burke","year":"2021","journal-title":"AIDS"},{"key":"2025110901582167300_ciaf175-B30","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1097\/QAD.0000000000003924","article-title":"Care interruptions and mortality among adults in Europe and North America: a collaborative analysis of cohort studies","volume":"38","author":"Trickey","year":"2024","journal-title":"AIDS"},{"key":"2025110901582167300_ciaf175-B31","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1017\/S0950268816000625","article-title":"Characteristics and consequences of medical care interruptions in HIV-infected patients in France","volume":"144","author":"Cuzin","year":"2016","journal-title":"Epidemiol Infect"},{"key":"2025110901582167300_ciaf175-B32","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12981-020-00296-x","article-title":"Addressing advanced HIV disease and mortality in global HIV programming","volume":"17","author":"Boyd","year":"2020","journal-title":"AIDS Res Ther"},{"key":"2025110901582167300_ciaf175-B33","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/QAI.0000000000000084","article-title":"Discontinuation of antiretroviral therapy among adults receiving HIV care in the United States","volume":"66","author":"Hughes","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025110901582167300_ciaf175-B34","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/aje\/kwad076","article-title":"The effect of HIV treatment interruption on subsequent immunological response","volume":"192","author":"Thomadakis","year":"2023","journal-title":"Am J Epidemiol"},{"key":"2025110901582167300_ciaf175-B35","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1093\/cid\/cix1140","article-title":"The continuing burden of advanced HIV disease over 10 years of increasing antiretroviral therapy coverage in South Africa","volume":"66","author":"Osler","year":"2018","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaf175\/62846630\/ciaf175.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/81\/4\/e108\/62846630\/ciaf175.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/81\/4\/e108\/62846630\/ciaf175.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T06:58:33Z","timestamp":1762671513000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/81\/4\/e108\/8104458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":35,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4,3]]},"published-print":{"date-parts":[[2025,11,6]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaf175","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10,15]]},"published":{"date-parts":[[2025,4,3]]}}}